Success Stories
Affected by primary infertility, In Vitro Fertilization (IVF) could not bring about a successful pregnancy as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 6mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 15 the thickness was 8.2mm and on day 22 it increased to a very favorable 11.2mm
The clinical pregnancy was reported positive
Affected by primary infertility, In Vitro Fertilization (IVF) was deemed ineffective as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 6.7mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 14 the thickness was 9mm and on day 20 it increased to a good 10.5mm
The clinical pregnancy was positive and she is going strong at 26 weeks of pregnancy.
Affected by primary infertility, In Vitro Fertilization (IVF) was unsuccessful, because of problems caused by a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.1mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 16 the thickness was 8.8mm and on day 21 it increased to an abundant 10.2mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) was ineffective, because of a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.8mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 15 the thickness was 8.9mm and on day 21 it increased to 10.2mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) did not result in successful conception, because of a thin endometrium (never grew beyond 8mm). The pre-treatment thickness was 7.9mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 14 the thickness was 10mm and on day 21 it increased to 11mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) was not a success as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 7.5mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 14 the thickness was 8.4mm and on day 19 it increased to a positive 10mm
The clinical pregnancy was positive and she successfully delivered a baby.
Affected by primary infertility, In Vitro Fertilization (IVF) did not yield a favorable result because of a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.6mm, and constant implantation failures were seen.
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage was administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 16 the thickness was 9.2mm and on day 21 it increased to an adequate 10.2mm
The clinical pregnancy was positive and she is going strong at 26 weeks of pregnancy.
Afflicted by infertility, In Vitro Fertilization (IVF) also did not bring positive results as the endometrium was thin (never grew beyond 7mm). The pre-treatment thickness was 7.1mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 15 the thickness was 9.2mm and on day 21 it increased to a very good 11mm
The clinical pregnancy was positive and she’s at her 21st week of pregnancy.
Affected by primary infertility, In Vitro Fertilization (IVF) could not bring about conception as the endometrium was thin (never grew beyond 7mm). The pre-treatment thickness was 7mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 14 the thickness was 8.2mm and on day 20 it increased to a positive 9.6mm
Positive clinical pregnancy leading to healthy twins delivered.
Affected by primary infertility, In Vitro Fertilization (IVF) was not successful as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 5.8mm
Two doses of 0.9 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 5 of MENSTURAL CYCLE; followed by second dosage on day 15. The thickness reported on Day 10 was 7.9mm and on day 22 it increased to 9.8mm
Currently the patient is at her 24th week of pregnancy.
Affected by primary infertility, In Vitro Fertilization (IVF) was unsuccessful as the endometrium was thin (never grew beyond 6mm), pre-treatment thickness was 6.7mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 14 the thickness was 7.8mm and on day 20 it increased to a good 10.2mm
Clinical pregnancy was positive
Affected by primary infertility, In Vitro Fertilization (IVF) was not successful, owing to the problems caused by a thin endometrium (never grew beyond 8mm). The pre-treatment thickness was 8mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 14 the thickness was 8.6mm and on day 20 it increased to an abundant 10.9mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) did not result in successful conception, because of a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.2mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 15 the thickness was 9.1mm and on day 21 it increased to 10.8mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) did not help in bringing about pregnancy, as the endometrium was thin (never grew beyond 7mm). The pre-treatment thickness was 7.2mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 16 the thickness was 9.1mm and on day 20 it increased to 10.9mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) failed because of a thin endometrium (never grew beyond 6mm). The pre-treatment thickness was 6.8mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage was administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 14 the thickness was 8.1mm and on day 20 it increased to a favorable 10.2mm
The clinical pregnancy was positive and she successfully delivered a baby.
Affected by primary infertility, In Vitro Fertilization (IVF) did not yield a positive result because of a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.2mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 15 the thickness was 8.9mm and on day 22 it increased to an impressive 10.5mm
The clinical pregnancy was positive and she is at her 26th week of pregnancy.
Affected by primary infertility, In Vitro Fertilization (IVF) did not bring positive results as the endometrium was thin (never grew beyond 7mm). The pre-treatment thickness was 6.8mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 14 the thickness was 8.4mm and on day 20 it increased to a positive 10.1mm
The clinical pregnancy was positive and she’s at her 21st week of pregnancy.
Affected by primary infertility, and 3 implantation failures owing to thin endometrium (never grew beyond 6mm). The pre-treatment thickness was 5.8mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 12 the thickness was 7.1mm and on day 20 it increased to a good 8.2mm
Positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) did not help in conceiving, due to a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.2mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 16 the thickness was 9.1mm and on day 22 it increased to a good 10.1mm
100% conditional improvement followed by positive clinical pregnancy, patient now at her 12th week of conception.
Affected by primary infertility, In Vitro Fertilization (IVF) was deemed ineffective, because of the problems caused by a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 6.9mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 14 the thickness was 8.8mm and on day 20 it increased to 10.1mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) did not result in a successful conception, because of a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 6.9mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 14 the thickness was 8.1mm and on day 22 it increased to 10.1mm
100% conditional improvement followed by positive clinical pregnancy
Affected by primary infertility, In Vitro Fertilization (IVF) failed as the endometrium was thin (never grew beyond 7mm). The pre-treatment thickness was 7mm
Two doses of 0.8ml of Autologous Biological Concentrate Dosage was administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 14 the thickness was 8.1mm and on day 21 it increased to 9.2mm
The clinical pregnancy was positive and she successfully delivered a baby.
Affected by primary infertility, In Vitro Fertilization (IVF) was futile, since the endometrium was thin (never grew beyond 7mm). The pre-treatment thickness was 7.2mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 7 of MENSTURAL CYCLE; on day 12 the thickness was 8.2mm and on day 20 it increased to a favorable 9.8mm
The clinical pregnancy was positive and she successfully delivered a baby.
Affected by primary infertility, In Vitro Fertilization (IVF) could not yield pregnancy since the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 5.2mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage was administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 15 the thickness was 8.1mm and on day 22 it increased to a very favorable 10.3mm
The clinical pregnancy was positive and she is at her 26th week of pregnancy.
Affected by primary infertility, In Vitro Fertilization (IVF) did not bring positive results as the endometrium was thin (never grew beyond 7mm). The pre-treatment thickness was 6.8mm
Two doses of 0.8 ml of Autologous Biological Concentrate Dosage were administered. Dose 1 was injected on day 6 of MENSTURAL CYCLE; on day 15 the thickness was 9.2mm and on day 21 it increased to a positive 10.2mm
Positive clinical pregnancy reported